Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrossword Cybersecurity Regulatory News (CCS)

  • This share is currently suspended. It was suspended at a price of 1.75
  • There is currently no data for CCS

Trading Update

11 Feb 2019 07:00

RNS Number : 5460P
Crossword Cybersecurity PLC
11 February 2019
 

11 February 2019

 

Crossword Cybersecurity plc

TRADING UPDATE

Crossword Cybersecurity plc (AIM: CCS, "Crossword", the "Company" or the "Group"), the technology commercialisation company focusing exclusively on the cyber security sector, is pleased to announce that it expects to report results in line with market expectations for the Financial Year ended 31 December 2018, in early April 2019.

Crossword expects to report revenue growth of 45%, with software related revenue increasing by more than 100%. A number of recurring revenue contracts for Rizikon Assurance, Crossword's Third Party Assurance Saas product, were secured towards the end of 2018 and early in 2019 in industry sectors including Health, IT Services, Nuclear & Professional Services, confirming management's confidence in the strength of the pipeline which has been building since mid-2018.

Tom Ilube, CEO of Crossword, commented,

"2018 was another productive year for Crossword, culminating in our admission to AIM on 14 December, where we raised £2m. The investment will help to continue to grow and convert the Group's current pipeline of £1.4 million which stretches over 30 companies in a wide range of sectors. We are well positioned to deliver a year of strong revenue growth.

Our in depth understanding of what's happening in academic cyber security research, alongside our current and developing relationships with research intensive European university partners, means Crossword is well placed to identify promising cyber security intellectual property (IP) from research, that our industry partners tell us meets emerging real-world challenges."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Contacts

Crossword Cybersecurity plc

Tel: +44 (0) 20 8973 2350

Email: info@crosswordcybersecurity.com

Tom Ilube, Chief Executive Officer

Mary Dowd, Finance Director

 

Grant Thornton (Nominated Adviser)

Tel: +44 (0) 20 7383 5100

Colin Aaronson / Jamie Barklem / Niall McDonald

Hybridan LLP (Broker)

Tel: +44 (0)203 764 2341

Claire Louise Noyce

 

About Crossword Cybersecurity plc

Crossword Cybersecurity plc focuses on the development and commercialisation of university research-based cyber security related software and cyber security consulting. The Group's specialist cyber security product development and software engineering teams work with its university partners to develop the research concept into a fully-fledged commercial product that it will then take to market. The Group's aim is to build up a portfolio of revenue generating, intellectual property based, cyber security products. Rizikon Assurance, Crossword's leading product, is a SaaS platform that enables medium to large companies to assess the cyber maturity and GDPR readiness of their suppliers. Crossword's team of expert cyber security consultants leverages years of experience in national security, defence and commercial cyber intelligence and operations to provide bespoke advice tailored to its clients' business needs. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFVEFIITIIA
Date   Source Headline
29th Nov 20073:54 pmRNSResult of AGM
7th Nov 20079:50 amRNSNotice of AGM
23rd Oct 200712:02 pmRNSContract wins
22nd Oct 20077:01 amRNSUpdate on Retail Division
4th Oct 200712:17 pmRNSStrategic Review
27th Sep 20073:05 pmRNSBoard changes
3rd Sep 200710:26 amRNSFinal Results
24th Aug 200711:29 amRNSAIM Rule 26 information
21st Aug 200712:12 pmRNSChange of registered office
20th Aug 20074:02 pmRNSChange of Broker
20th Jul 200712:59 pmRNSNotice of deferred results
3rd Jul 200710:15 amRNSDirectorate Change
29th Jun 20073:55 pmRNSChange of Adviser
26th Jun 20077:02 amRNSBoard Changes
6th Jun 200712:42 pmRNSTotal Voting Rights
31st May 20076:07 pmRNSResult of EGM
31st May 200712:43 pmRNSConfirmation of EGM Notice
23rd May 20071:05 pmRNSInterests in Shares
23rd May 20079:44 amRNSDirector/PDMR Shareholding
23rd May 20077:02 amRNSStrategic update
22nd May 20077:03 amRNSMarket Update
11th May 200712:25 pmRNSMAJOR INTERESTS IN SHARES
11th May 200712:19 pmRNSMAJOR INTERESTS IN SHARES
11th May 200712:08 pmRNSAdditional Listing
3rd May 20075:47 pmRNSNotice of EGM
3rd May 20071:47 pmRNSTotal Voting Rights
2nd May 20076:27 pmRNSHolding(s) in Company
1st May 20072:41 pmRNSDirector/PDMR Shareholding
26th Apr 200712:39 pmRNSBoard Appointment
16th Apr 20071:29 pmRNSStmnt re Requisition for EGM
2nd Apr 20077:01 amRNSTrading Statement
8th Jan 200712:07 pmRNSDirector Shareholding
4th Jan 20075:10 pmRNSDirector / PDMR Shareholding
22nd Dec 20061:22 pmRNSTotal Voting Rights
8th Dec 200610:42 amRNSContract win
30th Nov 20067:01 amRNSBoard Change
23rd Nov 20067:01 amRNSInterim Results
13th Nov 20069:28 amRNSInterim Results Notification
20th Sep 20066:10 pmRNSAGM Statement
29th Jun 20067:02 amRNSFinal Results
13th Jun 20062:43 pmRNSNotice of Results
2nd May 20067:03 amRNSDirectors Shareholding
26th Apr 20061:02 pmRNSDirector/PDMR Shareholding
25th Apr 20062:18 pmRNSResult of EGM
24th Apr 20067:01 amRNSPlacing of Shares
18th Apr 20067:02 amRNSDividend Policy
18th Apr 20067:02 amRNSTrading Statement
3rd Apr 20067:03 amRNSTrading Update
29th Mar 20067:03 amRNSAcquisition
15th Dec 20055:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.